These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1363511

  • 1. Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques.
    Molina R, Ciocca DR, Tandon AK, Allred DC, Clark GM, Chamness GC, Gullick WJ, McGuire WL.
    Anticancer Res; 1992; 12(6B):1965-71. PubMed ID: 1363511
    [Abstract] [Full Text] [Related]

  • 2. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
    Baak JP, Chin D, van Diest PJ, Ortiz R, Matze-Cok P, Bacus SS.
    Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
    [Abstract] [Full Text] [Related]

  • 3. Histopathologic characteristics predicting HER-2/neu amplification in breast cancer.
    Prati R, Apple SK, He J, Gornbein JA, Chang HR.
    Breast J; 2005 Feb; 11(6):433-9. PubMed ID: 16297088
    [Abstract] [Full Text] [Related]

  • 4. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R.
    Cancer Res; 1993 Oct 15; 53(20):4960-70. PubMed ID: 8104689
    [Abstract] [Full Text] [Related]

  • 5. HER-2/neu amplification predicts poor survival in node-positive breast cancer.
    Borg A, Tandon AK, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Killander D, McGuire WL.
    Cancer Res; 1990 Jul 15; 50(14):4332-7. PubMed ID: 1973070
    [Abstract] [Full Text] [Related]

  • 6. Quantitation of HER-2/neu oncoprotein overexpression in invasive breast cancer by image analysis: a study comparing fresh and paraffin-embedded material.
    van Diest PJ, Baak JP, Chin D, Theeuwes JW, Bacus SS.
    Anal Cell Pathol; 1991 Jul 15; 3(4):195-202. PubMed ID: 1679345
    [Abstract] [Full Text] [Related]

  • 7. Her-2/neu oncogene expression in Puerto Rican females with breast cancer.
    Peredo R, Sastre G, Serrano J, Hunter Mellado R.
    Cell Mol Biol (Noisy-le-grand); 2001 Sep 15; 47(6):1025-32. PubMed ID: 11785652
    [Abstract] [Full Text] [Related]

  • 8. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
    Matsubara H, Yamada Y, Naruse K, Nakamura K, Aoki S, Taki T, Tobiume M, Zennami K, Katsuda R, Honda N.
    Oncol Rep; 2008 Jan 15; 19(1):57-63. PubMed ID: 18097576
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH, Dervan PA, O'Regan M, Codd MB, Gullick WJ, Tobin BM, Carney DN.
    Cancer Res; 1991 Jun 15; 51(12):3296-303. PubMed ID: 1674898
    [Abstract] [Full Text] [Related]

  • 10. Do we need HER-2/neu testing for all patients with primary breast carcinoma?
    Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, Bachleitner T, Roka S, Fitzal F, Kandioler D, Sporn E, Friedl J, Mittlböck M, Jakesz R.
    Cancer; 2003 Dec 15; 98(12):2547-53. PubMed ID: 14669272
    [Abstract] [Full Text] [Related]

  • 11. Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.
    Naeem M, Nasir A, Aman Z, Ahmad T, Samad A.
    J Ayub Med Coll Abbottabad; 2008 Dec 15; 20(3):23-6. PubMed ID: 19610508
    [Abstract] [Full Text] [Related]

  • 12. HER-2/neu oncogene expression in advanced breast cancer.
    Krogerus LA, Leivonen M.
    Cancer Detect Prev; 2001 Dec 15; 25(1):1-7. PubMed ID: 11270416
    [Abstract] [Full Text] [Related]

  • 13. HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement.
    Jacobs TW, Gown AM, Yaziji H, Barnes MJ, Schnitt SJ.
    Am J Clin Pathol; 2000 Feb 15; 113(2):251-8. PubMed ID: 10664627
    [Abstract] [Full Text] [Related]

  • 14. Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related.
    Huang HJ, Neven P, Drijkoningen M, Paridaens R, Wildiers H, Van Limbergen E, Berteloot P, Amant F, Christiaens MR, Vergote I.
    Breast Cancer Res Treat; 2005 May 15; 91(1):81-7. PubMed ID: 15868434
    [Abstract] [Full Text] [Related]

  • 15. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O, el-Salahy E, Mahmoud M, Wahab MA, Eissa S, Khalifa A.
    Anticancer Res; 2002 May 15; 22(4):2493-9. PubMed ID: 12174951
    [Abstract] [Full Text] [Related]

  • 16. HER-2/neu overexpression in breast cancer: an immunohistochemical study including correlations with clinicopathologic parameters, p53 oncoprotein and cathepsin-D.
    Korkolis D, Ardavanis A, Yotis J, Kyroudi A, Gorgoulis V, Kittas C.
    Anticancer Res; 2001 May 15; 21(3C):2207-12. PubMed ID: 11501848
    [Abstract] [Full Text] [Related]

  • 17. [Immunohistochemical research on breast cancer cell proliferation and hormonal receptor status with special emphasis on HER-2/neu expression].
    Ohlinger R, Steffen SM, Oellig F, Köhler G, Schwesinger G, Lorenz G.
    Zentralbl Gynakol; 2002 Oct 15; 124(10):473-7. PubMed ID: 12712389
    [Abstract] [Full Text] [Related]

  • 18. HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger.
    Maru D, Middleton LP, Wang S, Valero V, Sahin A.
    Cancer; 2005 Mar 01; 103(5):900-5. PubMed ID: 15643600
    [Abstract] [Full Text] [Related]

  • 19. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL, Rosenthal SI, Brien TP, Stylos S, Johnson RL, Ross JS.
    Mod Pathol; 2000 May 01; 13(5):542-7. PubMed ID: 10824926
    [Abstract] [Full Text] [Related]

  • 20. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA, Mamoon N, Mushtaq S, Khadim MT.
    J Coll Physicians Surg Pak; 2009 Feb 01; 19(2):99-103. PubMed ID: 19208313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.